ATNM 8-K 2026-06-18

Actinium Pharmaceuticals, Inc. (ATNM) 8-K dated 2026-06-18 — accession 0001213900-26-070193. This URL is the filing, not the ATNM hub.

Actinium Pharmaceuticals, Inc. (ATNM) is a biotechnology company listed on US.

Actinium Pharmaceuticals, Inc. filed a 8-K on 2026-06-18. Accession 0001213900-26-070193.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.

Not investment advice. The ATNM SEC hub lists recent forms. The stock page is the research view.